secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2024-10-24T23:59:59+00:00
Accession:  0001193125-24-242806
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed Q1 FY2025 revenue $1.22B (+11% YoY); EPS $2.11; non-GAAP EPS $2.20; dividend $0.53
--------------------------------------------------------------------------------

- Revenue $1,224.5M, up 11% YoY (11% constant currency), driven by sleep device and mask demand.
- GAAP diluted EPS $2.11; non-GAAP diluted EPS $2.20, up 34% YoY; operating profit up 34%.
- Gross margin improved to 58.6% (non-GAAP 59.2%), up 420 bps YoY on manufacturing efficiencies.
- Operating cash flow $326M; paid $78M dividends and repurchased $50M shares.
- Board declared quarterly dividend of $0.53 per share, record date Nov 7, payable Dec 12.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312524242806/0001193125-24-242806-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312524242806/d859390d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-242806

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer